We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYRS
1176
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$129K ﹤0.01%
+932
New +$118K
GS.PRI.CL
1177
DELISTED
The Goldman Sachs Group, Inc.
GS.PRI.CL
$129K ﹤0.01%
5,000
– –
CNSL
1178
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$128K ﹤0.01%
5,100
– –
FMC icon
1179
FMC
FMC
$1.39B
$127K ﹤0.01%
3,035
– –
HL icon
1180
Hecla Mining
HL
$10.2B
$127K ﹤0.01%
22,500
-4,000
-15% -$24.5K
BECN
1181
DELISTED
Beacon Roofing Supply, Inc.
BECN
$127K ﹤0.01%
3,065
-86
-3% -$3.91K
AGU
1182
DELISTED
Agrium
AGU
$127K ﹤0.01%
1,412
+290
+26% +$26.7K
FPX icon
1183
First Trust US Equity Opportunities ETF
FPX
$1.51B
$126K ﹤0.01%
2,325
– –
KRE icon
1184
State Street SPDR S&P Regional Banking ETF
KRE
$4.47B
$126K ﹤0.01%
3,000
– –
SRCL
1185
DELISTED
Stericycle Inc
SRCL
$126K ﹤0.01%
1,580
-857
-35% -$77.5K
HURN icon
1186
Huron Consulting
HURN
$1.89B
$125K ﹤0.01%
2,119
– –
WBS icon
1187
Webster Financial
WBS
$12.5B
$125K ﹤0.01%
3,300
– –
NATI
1188
DELISTED
National Instruments Corp
NATI
$125K ﹤0.01%
4,429
-188
-4% -$5.28K
SRPT icon
1189
Sarepta Therapeutics
SRPT
$1.68B
$124K ﹤0.01%
2,038
+38
+2% +$1.15K
RENX
1190
DELISTED
RELX N.V.
RENX
$124K ﹤0.01%
+6,993
New +$124K
BAC.PRL icon
1191
Bank of America Series L
BAC.PRL
$3.97B
$122K ﹤0.01%
100
– –
IART icon
1192
Integra LifeSciences
IART
$1.52B
$122K ﹤0.01%
+2,970
New +$124K
CTSO icon
1193
Cytosorbents Corp
CTSO
$22.6M
$121K ﹤0.01%
19,008
– –
IYF icon
1194
iShares US Financials ETF
IYF
$4.68B
$121K ﹤0.01%
2,692
– –
LSXMK
1195
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$121K ﹤0.01%
4,791
-612
-11% -$15.5K
HIFR
1196
DELISTED
InfraREIT, Inc.
HIFR
$121K ﹤0.01%
6,699
+6,590
+6,046% +$119K
TVIA
1197
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$121K ﹤0.01%
44,300
– –
ITB icon
1198
iShares US Home Construction ETF
ITB
$2.35B
$120K ﹤0.01%
4,387
– –
KBE icon
1199
State Street SPDR S&P Bank ETF
KBE
$1.63B
$119K ﹤0.01%
3,600
– –
CSC
1200
DELISTED
Computer Sciences
CSC
$119K ﹤0.01%
2,300
-7,251
-76% -$350K
46 47
48
49 50

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.